Impact of calcified nodule on target lesion failure after stent implantation in hemodialysis patients

Abstract

AbstractBackgroundLittle is known about intravascular imaging predictors of cardiac events after drug‐eluting stent (DES) implantation in hemodialysis (HD) patients. We aimed to reveal the association between calcified nodules (CN) and target lesion failure (TLF) in HD patients after DES implantation.MethodsWe enrolled 114 HD patients who underwent DES implantation between October 2016 and October 2020. The patients were divided into a CN group (39%, 44 patients) and a non‐CN group (61%, 70 patients). The primary endpoint was the incidence of TLF, including cardiac death, target vessel myocardial infarction, and clinically driven target lesion revascularization.ResultsHD duration was longer, and the calcium burden was higher in the CN group than in the non‐CN group. Over a median follow‐up of 607 days [interquartile range: 349–965 days], the cumulative incidence curve showed that the CN group had a significantly higher incidence of TLF than the non‐CN group (31.8% vs. 11.4% within 3 years, p = 0.008).　On Fine‐Gray sub‐distribution hazard model analysis, the CN group was associated with an increased rate of TLF (hazard ratio [HR]: 2.86; 95% confidence interval [CI]: 1.21–6.75, p = 0.016). An in‐stent CN was observed in 73% of the lesions with target lesion revascularization in the CN group, whereas no in‐stent CN was observed in the non‐CN group (p = 0.026).ConclusionsCN was an independent predictor of TLF in patients undergoing HD. In‐stent CN was an important cause of TLF after DES implantation in CN lesions in HD patients; therefore, a different strategy should be considered for treating the lesions.